Friend or foe? IFNλ drives fibrosis
Journal of Experimental Medicine · 03.08.2026 · 223 (8)
DOI: 10.1084/jem.20260881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 06.07.2026. Verfasst von Ivan Zanoni. Beteiligte Einrichtung: Harvard Medical School, Boston Children's Hospital , Boston, MA, USA. Hauptthemen laut MEDLINE: Interferons, Kidney. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Type III IFNs, or IFNλ, are pleiotropic immune mediators that mostly work at mucosal surfaces by signaling in epithelial cells and selected immune cells. Zhou, Zhang, and colleagues (https://doi.org/10.1084/jem.20251858) demonstrate that IFNλ also signals in kidney fibroblasts sustaining renal fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Boston Children's Hospital , Boston, MA, USA.
ORCID-Profile: Ivan Zanoni
Zitieren
APA
Zanoni, I. (2026). Friend or foe? IFNλ drives fibrosis. Journal of Experimental Medicine, 223(8). https://doi.org/10.1084/jem.20260881
Vancouver
Zanoni I. Friend or foe? IFNλ drives fibrosis. Journal of Experimental Medicine. 2026;223(8). doi:10.1084/jem.20260881
BibTeX
@article{Zanoni2026,
author = {Zanoni, Ivan},
title = {Friend or foe? IFNλ drives fibrosis},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {8},
doi = {10.1084/jem.20260881}
}
EUVIMED